Amgen Inc Net Income
| AMGN Stock | USD 369.20 0.00 0.00% |
As of the 16th of February 2026, Amgen shows the mean deviation of 1.33, and Risk Adjusted Performance of 0.1047. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amgen Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.652 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 7.7 B | 8.1 B | |
| Net Income Applicable To Common Shares | 7.5 B | 5 B | |
| Net Income From Continuing Ops | 4.7 B | 6.3 B | |
| Net Income Per Share | 14.33 | 15.05 | |
| Net Income Per E B T | 0.86 | 0.64 |
Amgen | Net Income | Build AI portfolio with Amgen Stock |
Evaluating Amgen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.
Latest Amgen's Net Income Growth Pattern
Below is the plot of the Net Income of Amgen Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Amgen Inc financial statement analysis. It represents the amount of money remaining after all of Amgen Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Amgen's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 7.71 B | 10 Years Trend |
|
Net Income |
| Timeline |
Amgen Net Income Regression Statistics
| Arithmetic Mean | 5,733,355,882 | |
| Geometric Mean | 3,314,746,677 | |
| Coefficient Of Variation | 40.67 | |
| Mean Deviation | 1,858,469,550 | |
| Median | 6,552,000,000 | |
| Standard Deviation | 2,331,644,828 | |
| Sample Variance | 5436567.6T | |
| Range | 8.4B | |
| R-Value | 0.57 | |
| Mean Square Error | 3928274.8T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 262,253,431 | |
| Total Sum of Squares | 86985081.7T |
Amgen Net Income History
Other Fundumenentals of Amgen Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Amgen Net Income component correlations
Amgen Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Amgen is extremely important. It helps to project a fair market value of Amgen Stock properly, considering its historical fundamentals such as Net Income. Since Amgen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amgen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amgen's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Amgen diversify its offerings? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amgen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.116 | Dividend Share 9.52 | Earnings Share 14.21 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
Investors evaluate Amgen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amgen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Amgen's market price to deviate significantly from intrinsic value.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.
Amgen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amgen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amgen.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Amgen on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Amgen Inc or generate 0.0% return on investment in Amgen over 90 days. Amgen is related to or competes with Gilead Sciences, Pfizer, Sanofi ADR, Merck, Danaher, Bristol Myers, and Novo Nordisk. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide More
Amgen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amgen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amgen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.69 | |||
| Information Ratio | 0.0867 | |||
| Maximum Drawdown | 11.13 | |||
| Value At Risk | (2.62) | |||
| Potential Upside | 3.81 |
Amgen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amgen's standard deviation. In reality, there are many statistical measures that can use Amgen historical prices to predict the future Amgen's volatility.| Risk Adjusted Performance | 0.1047 | |||
| Jensen Alpha | 0.1826 | |||
| Total Risk Alpha | 0.0842 | |||
| Sortino Ratio | 0.1003 | |||
| Treynor Ratio | 0.2936 |
Amgen February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1047 | |||
| Market Risk Adjusted Performance | 0.3036 | |||
| Mean Deviation | 1.33 | |||
| Semi Deviation | 1.4 | |||
| Downside Deviation | 1.69 | |||
| Coefficient Of Variation | 816.34 | |||
| Standard Deviation | 1.95 | |||
| Variance | 3.82 | |||
| Information Ratio | 0.0867 | |||
| Jensen Alpha | 0.1826 | |||
| Total Risk Alpha | 0.0842 | |||
| Sortino Ratio | 0.1003 | |||
| Treynor Ratio | 0.2936 | |||
| Maximum Drawdown | 11.13 | |||
| Value At Risk | (2.62) | |||
| Potential Upside | 3.81 | |||
| Downside Variance | 2.86 | |||
| Semi Variance | 1.96 | |||
| Expected Short fall | (1.41) | |||
| Skewness | 1.13 | |||
| Kurtosis | 3.46 |
Amgen Inc Backtested Returns
As of now, Amgen Stock is very steady. Amgen Inc secures Sharpe Ratio (or Efficiency) of 0.0803, which signifies that the company had a 0.0803 % return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for Amgen Inc, which you can use to evaluate the volatility of the firm. Please confirm Amgen's mean deviation of 1.33, and Risk Adjusted Performance of 0.1047 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%. Amgen has a performance score of 6 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amgen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amgen is expected to be smaller as well. Amgen Inc right now shows a risk of 1.93%. Please confirm Amgen Inc information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to decide if Amgen Inc will be following its price patterns.
Auto-correlation | -0.44 |
Modest reverse predictability
Amgen Inc has modest reverse predictability. Overlapping area represents the amount of predictability between Amgen time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amgen Inc price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Amgen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 308.31 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Amgen Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Amgen Inc reported net income of 7.71 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
Amgen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in net income category among its peers.
Amgen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.Environmental | Governance | Social |
Amgen Institutional Holders
Institutional Holdings refers to the ownership stake in Amgen that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Amgen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amgen's value.| Shares | Northern Trust Corp | 2025-06-30 | 6.1 M | Norges Bank | 2025-06-30 | 6 M | Bank Of America Corp | 2025-06-30 | 5.6 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 5.3 M | Capital Research Global Investors | 2025-06-30 | 4.6 M | Ubs Group Ag | 2025-06-30 | 4.6 M | Royal Bank Of Canada | 2025-06-30 | 4.5 M | Goldman Sachs Group Inc | 2025-06-30 | 4.2 M | Amvescap Plc. | 2025-06-30 | 4.2 M | Vanguard Group Inc | 2025-06-30 | 53.7 M | Blackrock Inc | 2025-06-30 | 46.6 M |
Amgen Fundamentals
| Return On Equity | 1.06 | ||||
| Return On Asset | 0.0815 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.28 % | ||||
| Current Valuation | 244.47 B | ||||
| Shares Outstanding | 539 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 84.72 % | ||||
| Number Of Shares Shorted | 13.26 M | ||||
| Price To Earning | 22.74 X | ||||
| Price To Book | 22.98 X | ||||
| Price To Sales | 5.41 X | ||||
| Revenue | 36.75 B | ||||
| Gross Profit | 26.01 B | ||||
| EBITDA | 17.13 B | ||||
| Net Income | 7.71 B | ||||
| Cash And Equivalents | 11.48 B | ||||
| Cash Per Share | 21.51 X | ||||
| Total Debt | 54.6 B | ||||
| Current Ratio | 1.68 X | ||||
| Book Value Per Share | 16.06 X | ||||
| Cash Flow From Operations | 9.96 B | ||||
| Short Ratio | 5.06 X | ||||
| Earnings Per Share | 14.21 X | ||||
| Price To Earnings To Growth | 1.14 X | ||||
| Target Price | 345.56 | ||||
| Number Of Employees | 28 K | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 198.99 B | ||||
| Total Asset | 90.59 B | ||||
| Retained Earnings | (27.59 B) | ||||
| Working Capital | 5.93 B | ||||
| Current Asset | 38.52 B | ||||
| Current Liabilities | 8.67 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.82 % | ||||
| Net Asset | 90.59 B | ||||
| Last Dividend Paid | 9.52 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving against Amgen Stock
| 0.57 | VCYT | Veracyte | PairCorr |
| 0.5 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.48 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.46 | OSE | OSE Pharma SA | PairCorr |
| 0.46 | DXB | Dimerix Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Biotechnology sector continue expanding? Could Amgen diversify its offerings? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amgen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.116 | Dividend Share 9.52 | Earnings Share 14.21 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
Investors evaluate Amgen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Amgen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Amgen's market price to deviate significantly from intrinsic value.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.